4//SEC Filing
COHEN MARC A 4
Accession 0001209191-21-040278
CIK 0001662579other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:16 PM ET
Size
7.0 KB
Accession
0001209191-21-040278
Insider Transaction Report
Form 4
COHEN MARC A
Director10% Owner
Transactions
- Other
Common Stock
2021-06-14+92,817→ 98,936 total - Other
Common Stock
2021-06-14+22,598→ 1,874,805 total(indirect: See footnote)
Footnotes (2)
- [F1]Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001132945
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:16 PM ET
- Size
- 7.0 KB